Item request has been placed!
×
Item request cannot be made.
×
Processing Request
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Canellos GP; Duggan D; Johnson J; Niedzwiecki D
- Source:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Apr 15; Vol. 22 (8), pp. 1532-3.
- Publication Type:
Letter
- Language:
English
- Additional Information
- Source:
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
- Publication Information:
Publication: 2003- : Alexandria, VA : American Society of Clinical Oncology
Original Publication: New York, N.Y. : Grune & Stratton, c1983-
- Subject Terms:
- Accession Number:
11056-06-7 (Bleomycin)
5V9KLZ54CY (Vinblastine)
7GR28W0FJI (Dacarbazine)
80168379AG (Doxorubicin)
- Subject Terms:
ABVD protocol
- Publication Date:
Date Created: 20040416 Date Completed: 20040507 Latest Revision: 20220330
- Publication Date:
20240829
- Accession Number:
10.1200/JCO.2004.99.010
- Accession Number:
15084636
No Comments.